CNS Pharmaceuticals Inc. (CNSP)
2.20
-0.23 (-9.47%)
At close: Mar 03, 2025, 3:59 PM
2.24
1.77%
After-hours: Mar 03, 2025, 04:59 PM EST
CNS Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 548.72K | 10.06M | 5M | 14.04M | 7.24M | 282.74K | 110.54K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 104.75K | 482.81K | 1.26M | 334.14K | -0.00 | 95.2K | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.04M | 5.02M | 2.47M | 1.46M | 652.62K | 305.4K | 51.65K |
| Total Current Assets | 1.59M | 12.56M | 7.48M | 15.5M | 7.89M | 588.13K | 162.19K |
| Property-Plant & Equipment | 4.93K | 5.66K | 16.11K | 23.43K | 18.16K | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 109.68K | 488.47K | 1.28M | 357.57K | 18.16K | 95.2K | n/a |
| Total Assets | 1.7M | 13.05M | 8.76M | 15.85M | 7.91M | 683.33K | 162.19K |
| Account Payables | 5.83M | 3.68M | 1.98M | 946.33K | 289.5K | 128.87K | 57.5K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 23.6K | n/a |
| Short-Term Debt | 300.81K | 409.97K | 387.79K | 439.29K | n/a | 316.92K | 121.83K |
| Other Current Liabilities | n/a | 828.39K | 224.95K | 519.8K | 21.5K | 786.85K | 41.4K |
| Total Current Liabilities | 6.13M | 4.92M | 2.14M | 1.91M | 311K | 1.23M | 220.73K |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | n/a | 4.09M | n/a | n/a | n/a | 445.78K | 179.32K |
| Total Liabilities | 6.13M | 4.92M | 2.14M | 1.91M | 311K | 1.23M | 220.73K |
| Total Debt | 300.81K | 409.97K | 387.79K | 439.29K | n/a | 316.92K | 121.83K |
| Common Stock | 6.21K | 1.62K | 27.93K | 23.86K | 16.45K | 12.7K | 10.27K |
| Retained Earnings | -69.57M | -50.72M | -34.98M | -20.95M | -11.49M | -7.61M | -219.36K |
| Comprehensive Income | n/a | n/a | n/a | -0.00 | -0.00 | n/a | n/a |
| Shareholders Equity | -4.43M | 8.13M | 6.62M | 13.95M | 7.6M | -549.3K | -58.53K |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |